Patent · US Expired

Synthesis of acyclic nucleoside derivatives

US6184376A · kind A · utility

3Cited by
6References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 6, 1998
Grant dateFeb 6, 2001
Priority date
Expiry dateAug 6, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Methods and novel intermediates of the formula: ##STR1## wherein R.sub.6 and R.sub.7 are lower alkyl or benzyl or R.sub.6 and R.sub.7 taken together are --CH.sub.2 CH.sub.2 --, --CH.sub.2 CH.sub.2 CH.sub.2 -- or --CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 --, R.sub.8 is C.sub.1 -C.sub.21 alkyl or a C.sub.2 -C.sub.21 monounsaturated alkenyl, which may optionally be substituted with substitution substituents independently selected from the group consisting of hydroxy, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, C.sub.1 -C.sub.6 alkoxy C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkanoyl, amino, halo, cyano, azido, oxo, mercapto and nitro, and R.sub.9 is an alcohol protecting group. The intermediates are useful for the preparation of acyclic nucleoside derivatives of the formula: ##STR2## where one of R.sub.1 and R.sub.2 is an amino acid acyl group and the other of R.sub.1 and R.sub.2 is a --C(O)C.sub.3 -C.sub.21 saturated or monounsaturated, optionally substituted alkyl and R.sub.3 is OH or H; or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.